- Home
- RYDE vs SNSE Comparison
RYDE vs SNSE Comparison
Compare RYDE & SNSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RYDE
- SNSE
- Stock Information
- Founded
- RYDE 2014
- SNSE 2005
- Country
- RYDE Singapore
- SNSE United States
- Employees
- RYDE N/A
- SNSE N/A
- Industry
- RYDE
- SNSE Biotechnology: Pharmaceutical Preparations
- Sector
- RYDE
- SNSE Health Care
- Exchange
- RYDE NYSE
- SNSE Nasdaq
- Market Cap
- RYDE 13.9M
- SNSE 12.3M
- IPO Year
- RYDE 2024
- SNSE 2021
- Fundamental
- Price
- RYDE $0.40
- SNSE $0.50
- Analyst Decision
- RYDE Strong Buy
- SNSE Strong Buy
- Analyst Count
- RYDE 1
- SNSE 3
- Target Price
- RYDE $9.00
- SNSE $4.33
- AVG Volume (30 Days)
- RYDE 497.7K
- SNSE 415.6K
- Earning Date
- RYDE 12-03-2024
- SNSE 11-14-2024
- Dividend Yield
- RYDE N/A
- SNSE N/A
- EPS Growth
- RYDE N/A
- SNSE N/A
- EPS
- RYDE N/A
- SNSE N/A
- Revenue
- RYDE $5,761,982.00
- SNSE N/A
- Revenue This Year
- RYDE $2.61
- SNSE N/A
- Revenue Next Year
- RYDE $21.90
- SNSE N/A
- P/E Ratio
- RYDE N/A
- SNSE N/A
- Revenue Growth
- RYDE N/A
- SNSE N/A
- 52 Week Low
- RYDE $0.40
- SNSE $0.38
- 52 Week High
- RYDE $22.49
- SNSE $1.94
- Technical
- Relative Strength Index (RSI)
- RYDE N/A
- SNSE 48.18
- Support Level
- RYDE N/A
- SNSE $0.43
- Resistance Level
- RYDE N/A
- SNSE $0.53
- Average True Range (ATR)
- RYDE 0.00
- SNSE 0.05
- MACD
- RYDE 0.00
- SNSE -0.00
- Stochastic Oscillator
- RYDE 0.00
- SNSE 44.38
About RYDE RYDE GROUP LTD
Ryde Group Ltd is a company providing a super mobility app offering ultimate convenience and reliability for their customers through multiple mobility tools that can be accessed and function seamlessly out of a single app. The company operates in the following segments such as being mobility where it provides on-demand and scheduled carpooling and ride-hailing services, matching riders to driver partners; and quick commerce where it provides on-demand, scheduled, and multi-stop parcel delivery services.
About SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing highly selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101, SNS-102, SNS-103, SNS-20.